Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Takeshima

Showing results (161-170 of 317) with videos related to

Pageof 32
Sort By:
Brain & Development|December 24, 2017
Novel BICD2 mutation in a Japanese family with autosomal dominant lower extremity-predominant spinal muscular atrophy-2Mieko Yoshioka, Naoya Morisada, Daisaku Toyoshima, et al.
Nature Communications|May 11, 2011
Chemical treatment enhances skipping of a mutated exon in the dystrophin geneAtsushi Nishida, Naoyuki Kataoka, Yasuhiro Takeshima, et al.
International Journal of Neonatal Screening|November 29, 2021
DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in <i>G6PC</i> by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve AnalysisEmma Tabe Eko Niba, Yogik Onky Silvana Wijaya, Hiroyuki Awano, et al.
The Kobe Journal of Medical Sciences|March 21, 2015
Phosphorothioate modification of chimeric 2´-O-methyl RNA/ethylene-bridged nucleic acid oligonucleotides increases dystrophin exon 45 skipping capability and reduces cytotoxicityRusdy Ghazali Malueka, Ery Kus Dwianingsih, Mariko Yagi, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 15, 2013
Early inhibition of natriuresis suppresses symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhageIchiro Nakagawa, Yasuo Hironaka, Fumihiko Nishimura, et al.
Translational Stroke Research|May 7, 2021
Hypocapnia Induced by Hyperventilation with Indocyanine Green Kinetics Detects the Effect of Staged Carotid Angioplasty to Avoid Hyperperfusion in Patients with Impaired Cerebral Hemodynamic ReserveIchiro Nakagawa, HunSoo Park, Masashi Kotsugi, et al.
Genes|October 26, 2024
Clinical and Genetic Profiles of 5q- and Non-5q-Spinal Muscular Atrophy Diseases in Pediatric PatientsHisahide Nishio, Emma Tabe Eko Niba, Toshio Saito, et al.
BMC Genetics|April 3, 2012
Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markersRusdy Ghazali Malueka, Yutaka Takaoka, Mariko Yagi, et al.
Genes|April 23, 2022
High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed <i>SMN2</i> Splicing in Patient FibroblastsYogik Onky Silvana Wijaya, Emma Tabe Eko Niba, Hisahide Nishio, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 24, 2020
Retrospective evaluations revealed pre-symptomatic citrulline concentrations measured by newborn screening were significantly low in late-onset ornithine transcarbamylase deficiency patientsTomoko Lee, Katsuhiko Yoshii, Satoru Yoshida, et al.
Pageof 32

Showing results (161-170 of 317) with videos related to

Sort By:
Pageof 32
Brain & Development|December 24, 2017
Novel BICD2 mutation in a Japanese family with autosomal dominant lower extremity-predominant spinal muscular atrophy-2Mieko Yoshioka, Naoya Morisada, Daisaku Toyoshima, et al.
Nature Communications|May 11, 2011
Chemical treatment enhances skipping of a mutated exon in the dystrophin geneAtsushi Nishida, Naoyuki Kataoka, Yasuhiro Takeshima, et al.
International Journal of Neonatal Screening|November 29, 2021
DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in <i>G6PC</i> by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve AnalysisEmma Tabe Eko Niba, Yogik Onky Silvana Wijaya, Hiroyuki Awano, et al.
The Kobe Journal of Medical Sciences|March 21, 2015
Phosphorothioate modification of chimeric 2´-O-methyl RNA/ethylene-bridged nucleic acid oligonucleotides increases dystrophin exon 45 skipping capability and reduces cytotoxicityRusdy Ghazali Malueka, Ery Kus Dwianingsih, Mariko Yagi, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 15, 2013
Early inhibition of natriuresis suppresses symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhageIchiro Nakagawa, Yasuo Hironaka, Fumihiko Nishimura, et al.
Translational Stroke Research|May 7, 2021
Hypocapnia Induced by Hyperventilation with Indocyanine Green Kinetics Detects the Effect of Staged Carotid Angioplasty to Avoid Hyperperfusion in Patients with Impaired Cerebral Hemodynamic ReserveIchiro Nakagawa, HunSoo Park, Masashi Kotsugi, et al.
Genes|October 26, 2024
Clinical and Genetic Profiles of 5q- and Non-5q-Spinal Muscular Atrophy Diseases in Pediatric PatientsHisahide Nishio, Emma Tabe Eko Niba, Toshio Saito, et al.
BMC Genetics|April 3, 2012
Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markersRusdy Ghazali Malueka, Yutaka Takaoka, Mariko Yagi, et al.
Genes|April 23, 2022
High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed <i>SMN2</i> Splicing in Patient FibroblastsYogik Onky Silvana Wijaya, Emma Tabe Eko Niba, Hisahide Nishio, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 24, 2020
Retrospective evaluations revealed pre-symptomatic citrulline concentrations measured by newborn screening were significantly low in late-onset ornithine transcarbamylase deficiency patientsTomoko Lee, Katsuhiko Yoshii, Satoru Yoshida, et al.
Pageof 32